PHARMACYTE BIOTECH, INC. Amortization of Debt Issuance Costs and Discounts
PHARMACYTE BIOTECH, INC. (PMCB) reported Amortization of Debt Issuance Costs and Discounts of $0 for the 12-month period ending 2014-04-30, per its 10-K filed 2014-08-04.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfFinancingCostsAndDiscounts · last filed 2014-08-04
- PHARMACYTE BIOTECH, INC. amortization of debt issuance costs and discounts for fiscal 2014 was $0.00.
- PHARMACYTE BIOTECH, INC. amortization of debt issuance costs and discounts for fiscal 2013 was -$5.70K.
| Period end | Amortization of Debt Issuance Costs and Discounts 12 month |
|---|---|
| 2014-04-30 | $0.00 10-K · filed 2014-08-04 |
| 2013-04-30 | -$5.70K 10-K · filed 2014-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |